Cargando…
Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease
Mannitol, a natural alcoholic-sugar, was recently suggested as a potential disease-modifying agent in Parkinson's disease. In animal models of the disease, mannitol interferes with the formation of α-synuclein fibrils, inhibits the formation of α-synuclein oligomers and leads to phenotypic reco...
Autores principales: | Linetsky, Eduard, Abd Elhadi, Suaad, Bauer, Max, Gallant, Akiva, Namnah, Montaser, Weiss, Sagit, Segal, Daniel, Sharon, Ronit, Arkadir, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761891/ https://www.ncbi.nlm.nih.gov/pubmed/35046880 http://dx.doi.org/10.3389/fneur.2021.716126 |
Ejemplares similares
-
α‐Synuclein in blood cells differentiates Parkinson’s disease from healthy controls
por: Abd Elhadi, Suaad, et al.
Publicado: (2019) -
Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson’s Disease
por: Abd-Elhadi, Suaad, et al.
Publicado: (2015) -
A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease
por: Schechter, Meir, et al.
Publicado: (2020) -
α-Synuclein Translocates to the Nucleus to Activate Retinoic-Acid-Dependent Gene Transcription
por: Davidi, Dana, et al.
Publicado: (2020) -
α-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate
por: Schechter, Meir, et al.
Publicado: (2021)